Victory Capital Management Inc Regenerx Biopharmaceuticals Inc Transaction History

Victory Capital Management Inc

  • $95.8 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 04, 2020
SELL
$0.14 - $0.3 $42 - $91
-305 Reduced 2.22%
13,440 $3,000
Q4 2019

Feb 04, 2020
BUY
$0.13 - $0.18 $1,786 - $2,474
13,745 New
13,745 $4,000

About REGENERX BIOPHARMACEUTICALS INC

RGRX Quotes by TradingView
  • Ticker RGRX
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,550,000
  • Description
  • RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; ...
More about RGRX
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email